GlassScriptPhysician profile
Josephine A Previlon
NPI 1629028287
$1,546.44
in general payments reported to CMS, 2019-2025
12 companies · $321 in 2025
The $321 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $213 · 2022: $127 · 2023: $427 · 2024: $458 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,043 · Education: $163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,043.17 |
| Education | $162.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $301.72 | 2023-2025 | Tecvayli, Darzalex, Imbruvica |
| Actelion Pharmaceuticals US, INC. | $275.00 | 2023-2024 | Opsumit, Uptravi |
| Astrazeneca Pharmaceuticals LP | $237.84 | 2021-2025 | Breztri |
| Astellas Pharma US INC | $188.06 | 2023-2025 | Cresemba |
| Genzyme Corporation | $127.00 | 2022 | |
| Mylan Specialty L.P. | $121.47 | 2024 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.44 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.11 | 2025 | |
| Incyte Corporation | $42.81 | 2025 | Monjuvi, Jakafi |
| Sobi, INC | $36.40 | 2024 | |
| Legend Biotech USA INC. | $30.50 | 2025 | Carvykti |
| Pharmacyclics LLC, An Abbvie Company | $14.09 | 2023 | Epkinly |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Josephine Previlon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.